Guidant
This article was originally published in The Gray Sheet
Executive Summary
Firm announces Oct. 6 it has launched its MultiLink Vision RX coronary stent system in Japan. Guidant's cobalt chromium stent technology will be the platform for its XIENCE V everolimus-eluting system, which is being compared with Boston Scientific's Taxus Express 2 paclitaxel-eluting stent in the SPIRIT II and III trials (1"The Gray Sheet" Sept. 26, 2005, In Brief)...